相关实验视频
Updated: Jun 11, 2025

12:19
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
60.3K
P16INK4A驱动RB1通过UTP14A催化K810无处不在化驱动RB1降解
Wenjie Weng1, Baozhen Zhang1, Dajun Deng1
1Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing) Division of Etiology, Peking University Cancer Hospital and Institute, Beijing 100142, China.
iScience
|October 1, 2024
概括
该研究显示,P16INK4A通过UTP14A促进RB1降解,形成负反循环. 这个P16INK4A-UTP14A-RB1轴影响细胞循环调节和蛋白质组无化,提供潜在的抗癌药物标.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 在癌症中,P16INK4A和RB1的表达是反向相关的.
- P16INK4A 抑制 CDK4 介导的 RB1 酸化.
- 通过P16INK4A和RB1协调调节细胞循环,需要进一步研究.
研究的目的:
- 阐明P16INK4A和RB1.1.之间的监管关系.
- 调查P16INK4A在RB1无化和降解中的作用.
- 探索P16INK4A在调节蛋白质尺度无化和细胞增殖中的功能.
主要方法:
- 西方涂抹以评估蛋白质水平和无处不在.
- 免疫沉以研究蛋白质相互作用.
- 细胞周期分析以评估增殖.
主要成果:
- P16INK4A对E3结合酶UTP14A进行上调,促进RB1在K810处的泛化和随后的降解.
- 失去P16INK4A会破坏UTP14A介导的RB1降解,导致RB1积累.
- P16INK4A的损失抑制了RB1的无化,这与细胞循环的进展无关.
- P16INK4A以细胞循环依赖的方式调节蛋白质基因规模的无化,抑制细胞的增殖.
结论:
- 在P16INK4A和RB1表达之间存在负反循环.
- 这一循环的破坏可以部分挽救P16INK4A损失的生物结果.
- P16INK4A在调节蛋白质组规模的无化和抑制细胞增殖方面发挥了新的作用,为癌症提供了潜在的治疗标.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K

